Go Pro
→ I found Rolls-Royce at $2 - now I see the same setup again (From Monument Traders Alliance) (Ad)tc pixel Free RCKTW Stock Alerts

Rocket Pharmaceuticals (RCKTW) Competitors

Rocket Pharmaceuticals logo
$0.0028 0.00 (-6.60%)
As of 11:01 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

RCKTW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Rocket Pharmaceuticals stock or one of its competitors? MarketBeat compares Rocket Pharmaceuticals with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Rocket Pharmaceuticals include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Rocket Pharmaceuticals compare to Ainos?

Ainos (NASDAQ:AIMDW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
Rocket PharmaceuticalsN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Rocket Pharmaceuticals N/A N/A N/A

In the previous week, Ainos' average media sentiment score of 0.00 equaled Rocket Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Ainos Neutral
Rocket Pharmaceuticals Neutral

Summary

Ainos beats Rocket Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

How does Rocket Pharmaceuticals compare to Alvotech?

Rocket Pharmaceuticals (NASDAQ:RCKTW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rocket PharmaceuticalsN/AN/AN/AN/AN/A
Alvotech$559.42MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Rocket PharmaceuticalsN/A N/A N/A
Alvotech N/A N/A N/A

In the previous week, Rocket Pharmaceuticals' average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company Overall Sentiment
Rocket Pharmaceuticals Neutral
Alvotech Neutral

Summary

Alvotech beats Rocket Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

How does Rocket Pharmaceuticals compare to Aravive?

Aravive (NASDAQ:ARAV) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Rocket Pharmaceuticals N/A N/A N/A

In the previous week, Aravive's average media sentiment score of 0.00 equaled Rocket Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Aravive Neutral
Rocket Pharmaceuticals Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Rocket PharmaceuticalsN/AN/AN/AN/AN/A

Summary

Aravive beats Rocket Pharmaceuticals on 2 of the 2 factors compared between the two stocks.

How does Rocket Pharmaceuticals compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Rocket Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Rocket Pharmaceuticals Neutral

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Rocket Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Rocket PharmaceuticalsN/AN/AN/AN/AN/A

Summary

Atlantic Coastal Acquisition Corp. II and Rocket Pharmaceuticals tied by winning 0 of the 0 factors compared between the two stocks.

How does Rocket Pharmaceuticals compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Rocket Pharmaceuticals (NASDAQ:RCKTW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled Rocket Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Rocket Pharmaceuticals Neutral

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Rocket Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
Rocket PharmaceuticalsN/AN/AN/AN/AN/A

Summary

Biofrontera beats Rocket Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

Get Rocket Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCKTW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RCKTW vs. The Competition

Export
MetricRocket PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$525.16M$6.89B$12.28B
Dividend YieldN/A3.90%2.67%9.39%
P/E RatioN/A3.5127.1023.94
Price / SalesN/A6,313.86517.5191.95
Price / CashN/A13.1326.6847.25
Price / BookN/A89.5410.666.14
Net IncomeN/A-$96.07M$3.60B$331.74M
7 Day PerformanceN/A-0.86%-1.51%-1.72%
1 Month PerformanceN/A0.94%1.11%-1.44%
1 Year PerformanceN/A54.67%23.77%16.97%

Rocket Pharmaceuticals Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RCKTW
Rocket Pharmaceuticals
N/A$0.00
-6.6%		N/A-93.5%$0.00N/AN/A240
AIMDW
Ainos
N/A$0.15
-3.3%		N/A-28.6%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.13
flat		N/AN/A$0.00$559.42MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:RCKTW) was last updated on 7/20/2026 by MarketBeat.com Staff.
From Our Partners
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
Sam Altman backs small company that could save U.S. power grid
A small Colorado company holds the rights to technology that could protect the U.S. public power grid from col...
Altimetry | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
I found Rolls-Royce at $2 - now I see the same setup again
In 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had wri...
Monument Traders Alliance | Sponsoredtc pixel
This tiny piece of glass could be bigger than GPUs
Jensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...
Brownstone Research | Sponsoredtc pixel
NVIDIA offered $40B. The answer was no.
Apple, NVIDIA, Google, Amazon, and Samsung all pay one company billions in royalties every year. NVIDIA tried ...
Behind the Markets | Sponsoredtc pixel